The FCRL3 −169T>C polymorphism might be associated with some autoantibody presence in patients with SLE in a Polish population

References

• Agmon-Levin N, Mosca M, Petri M, Shoenfeld Y. Systemic lupus erythematosus one disease or many?. Autoimmun Rev. 2012;11: 593–595.
   PubMed Web of Science ®Google Scholar
• Calero I, Sanz I. Targeting B cells for the treatment of SLE: the beginning of the end or the end of the beginning?. Discov Med. 2010;10: 416–424.
   PubMed Web of Science ®Google Scholar
• Truedsson L, Bengtsson AA, Sturfelt G. Complement deficiencies and systemic lupus erythematosus. Autoimmunity. 2007;40: 560–566.
   PubMed Web of Science ®Google Scholar
• Jönsen A, Bengtsson AA, Nived O, Truedsson L, Sturfelt G. Gene-environment interactions in the aetiology of systemic lupus erythematosus. Autoimmunity. 2007;40: 613–617.
   PubMed Web of Science ®Google Scholar
• Zandman-Goddard G, Solomon M, Rosman Z, Peeva E, Shoenfeld Y. Environment and lupus-related diseases. Lupus. 2012;21: 241–250.
   PubMed Web of Science ®Google Scholar
• Vaughn SE, Kottyan LC, Munroe ME, Harley JB. Genetic susceptibility to lupus: the biological basis of genetic risk found in B cell signaling pathways. J Leukoc Biol. 2012;92: 577–591.
   PubMed Web of Science ®Google Scholar
• Wong M, Tsao BP. Current topics in human SLE genetics. Springer Semin Immunopathol. 2006;28: 97–107.
   PubMed Web of Science ®Google Scholar
• Sestak AL, Fürnrohr BG, Harley JB, Merrill JT, Namjou B. The genetics of systemic lupus erythematosus and implications for targeted therapy. Ann Rheum Dis. 2011;70: i37–i43.
   PubMed Web of Science ®Google Scholar
• Kochi Y, Yamada R, Suzuki A, Harley JB, Shirasawa S, Sawada T, et al. A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities. Nat Genet. 2005;37: 478–485.
   PubMed Web of Science ®Google Scholar
• Tamiya G, Shinya M, Imanishi T, Ikuta T, Makino S, Okamoto K, et al. Whole-genome association study of rheumatoid arthritis using 27 039 microsatellites. Hum Mol Genet. 2005;14: 2305–2321.
   PubMed Web of Science ®Google Scholar
• Davis RS, Wang YH, Kubagawa H, Cooper MD. Identification of a family of Fc receptor homologs with preferential B cell expression. Proc Natl Acad Sci USA. 2001;98: 9772–9777.
   PubMed Web of Science ®Google Scholar
• Ehrhardt GR, Leu CM, Zhang S, Aksu G, Jackson T, Haga C, et al. Fc receptor-like proteins (FCRL): immunomodulators of B cell function. Adv Exp Med Biol. 2007;596: 155–162.
   PubMed Web of Science ®Google Scholar
• Davis RS. Fc receptor-like molecules. Annu Rev Immunol. 2007;25: 525–560.
   PubMed Web of Science ®Google Scholar
• Ramírez-Bello J, Jiménez-Morales S, Espinosa-Rosales F, Gómez-Vera J, Gutiérrez A, Velázquez Cruz R, et al. Juvenile rheumatoid arthritis and asthma, but not childhood-onset systemic lupus erythematosus are associated with FCRL3 polymorphisms in Mexicans. Mol Immunol. 2012;53: 374–378.
   PubMed Web of Science ®Google Scholar
• Chen JY, Wang CM, Wu YJ, Kuo SN, Shiu CF, Chang SW, et al. Disease phenotypes and gender association of FCRL3 single-nucleotide polymorphism −169T/C in Taiwanese patients with systemic lupus erythematosus and rheumatoid arthritis. J Rheumatol. 2011;38: 264–270.
   PubMed Web of Science ®Google Scholar
• Eike MC, Nordang GB, Karlsen TH, Boberg KM, Vatn MHIBSEN study groupet al. The FCRL3 −169T>C polymorphism is associated with rheumatoid arthritis and shows suggestive evidence of involvement with juvenile idiopathic arthritis in a Scandinavian panel of autoimmune diseases. Ann Rheum Dis. 2008;67: 1287–1291.
   PubMed Web of Science ®Google Scholar
• Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthr Rheum. 1982;25: 1271–1277.
   PubMed Web of Science ®Google Scholar
• Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthr Rheum. 1997;40: 1725.
   PubMed Web of Science ®Google Scholar
• Calero I, Sanz I, Crispín JC, Tsokos GC. Novel molecular targets in the treatment of systemic lupus erythematosus. Autoimmun Rev. 2008;7: 256–261.
   PubMed Web of Science ®Google Scholar
• Januchowski R, Wudarski M, Chwalińska-Sadowska H, Jagodzinski PP. Prevalence of ZAP-70, LAT, SLP-76, and DNA methyltransferase 1 expression in CD4(+) T cells of patients with systemic lupus erythematosus. Clin Rheumatol. 2008;27: 21–27.
   PubMed Web of Science ®Google Scholar
• Nagata S, Ise T, Pastan I. Fc receptor-like 3 protein expressed on IL-2 nonresponsive subset of human regulatory T cells. J Immunol. 2009;182: 7518–7526.
   PubMed Web of Science ®Google Scholar
• Swainson LA, Mold JE, Bajpai UD, McCune JM. Expression of the autoimmune susceptibility gene FcRL3 on human regulatory T cells is associated with dysfunction and high levels of programmed cell death-1. J Immunol. 2010;184: 3639–3647.
   PubMed Web of Science ®Google Scholar
• Kochi Y, Myouzen K, Yamada R, Suzuki A, Kurosaki T, Nakamura Y, et al. FCRL3, an autoimmune susceptibility gene, has inhibitory potential on B-cell receptor-mediated signaling. J Immunol. 2009;183: 5502–5510.
   PubMed Web of Science ®Google Scholar
• Choi CB, Kang CP, Seong SS, Bae SC, Kang C. The −169C/T polymorphism in FCRL3 is not associated with susceptibility to rheumatoid arthritis or systemic lupus erythematosus in a case-control study of Koreans. Arthr Rheum. 2006;54: 3838–3841.
   PubMedGoogle Scholar
• You Y, Wang Z, Deng G, Hao F. Lack of association between Fc receptor-like 3 gene polymorphisms and systemic lupus erythematosus in Chinese population. J Dermatol Sci. 2008;52: 118–122.
   PubMed Web of Science ®Google Scholar
• Sanchez E, Callejas JL, Sabio JM, de Haro M, Camps M, Ramón E, et al. Polymorphisms of the FCRL3 gene in a Spanish population of systemic lupus erythematosus patients. Rheumatology (Oxford). 2006;45: 1044–1046.
   PubMed Web of Science ®Google Scholar
• Wu H, Yang LH, Zuo J, Liang YL, Li PQ, Liu W, et al. Fc receptor-like 3 gene polymorphisms confer susceptibility to rheumatoid arthritis in a Chinese population. Hum Immunol. 2010;71: 1203–1208.
   PubMed Web of Science ®Google Scholar
• Maehlen MT, Nordang GB, Syversen SW, van der Heijde DM, Kvien TK, Uhlig T, et al. FCRL3 −169C/C genotype is associated with anti-citrullinated protein antibody-positive rheumatoid arthritis and with radiographic progression. J Rheumatol. 2011;38:2329–35.
   PubMed Web of Science ®Google Scholar
• Plagnol V, Howson JM, Smyth DJ, Walker N, Hafler JP, Wallace C, Type 1 Diabetes Genetics Consortium, Bingley PJ, Gough SC, Todd JA, et al. Genome-wide association analysis of autoantibody positivity in type 1 diabetes cases. PLoS Genet. 2011;8:e1002216.
   Google Scholar
• Gibson AW, Li FJ, Wu J, Edberg JC, Su K, Cafardi J, et al. The FCRL3−169CT promoter single-nucleotide polymorphism, which is associated with systemic lupus erythematosus in a Japanese population, predicts expression of receptor protein on CD19 + B cells. Arthr Rheum 200960:3510–3512.
   Google Scholar
• Tanaka A, Ohira H, Kikuchi K, Nezu S, Shibuya A, Bianchi I, et al. Genetic association of Fc receptor-like 3 polymorphisms with susceptibility to primary biliary cirrhosis: ethnic comparative study in Japanese and Italian patients. Tissue Antigens. 2011;77: 239–243.
   PubMedGoogle Scholar
• Bianco B, André GM, Vilarino FL, Peluso C, Mafra FA, Christofolini DM, et al. The possible role of genetic variants in autoimmune-related genes in the development of endometriosis. Hum Immunol. 2012;73: 306–315.
   PubMed Web of Science ®Google Scholar